Roche Molecular Systems Director of Business Development Salaries in San Francisco
The average Roche Molecular Systems Director of Business Development in San Francisco earns an estimated $227,955 annually, which includes an estimated base salary of $177,823 with a $50,132 bonus. Roche Molecular Systems' Director of Business Development compensation is $61,652 more than the US average for a Director of Business Development. Director of Business Development salaries at Roche Molecular Systems in San Francisco can range from $120,000 - $390,000.
In San Francisco, The Business Development Department at Roche Molecular Systems earns $757 more on average than the Design Department.
Last updated a year ago.
- $177,823
- avg. base
- $50,132
- avg. bonus
Director of Business Development Salaries at Roche Molecular Systems
In San Francisco, Directors of Business Development earn $3,336 more than Directors of Business Development.
Compensation at Roche Molecular Systems by Department
In San Francisco, The Business Development Department averages $757 more than the Design Department, and $2,814 less than the HR Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Roche Molecular Systems reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Roche Molecular Systems reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Roche Molecular Systems Rate Their Compensation
The majority of Directors of Business Development at Roche Molecular Systems believe they're compensated fairly. 100% of Directors of Business Development at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
